New York State Teachers Retirement System raised its holdings in shares of Acadia Healthcare Company Inc (NASDAQ:ACHC) by 118.8% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 17,500 shares of the company’s stock after purchasing an additional 9,500 shares during the period. New York State Teachers Retirement System’s holdings in Acadia Healthcare were worth $440,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Advisor Group Holdings Inc. bought a new position in shares of Acadia Healthcare during the first quarter valued at approximately $38,000. Exane Derivatives bought a new position in shares of Acadia Healthcare during the first quarter valued at approximately $60,000. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Acadia Healthcare by 25.4% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,091 shares of the company’s stock valued at $130,000 after purchasing an additional 1,436 shares in the last quarter. US Bancorp DE increased its stake in shares of Acadia Healthcare by 23.0% during the first quarter. US Bancorp DE now owns 13,058 shares of the company’s stock valued at $239,000 after purchasing an additional 2,442 shares in the last quarter. Finally, Macquarie Group Ltd. bought a new position in shares of Acadia Healthcare during the fourth quarter valued at approximately $251,000.
Shares of Acadia Healthcare stock opened at $29.81 on Friday. The company’s fifty day simple moving average is $26.58 and its 200-day simple moving average is $26.65. The stock has a market capitalization of $2.65 billion, a PE ratio of 23.29, a P/E/G ratio of 2.29 and a beta of 1.37. Acadia Healthcare Company Inc has a 1-year low of $11.09 and a 1-year high of $35.30. The company has a debt-to-equity ratio of 1.39, a current ratio of 0.87 and a quick ratio of 0.87.
Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Monday, May 4th. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.04. The company had revenue of $782.81 million for the quarter, compared to analysts’ expectations of $792.55 million. Acadia Healthcare had a net margin of 3.61% and a return on equity of 7.40%. Acadia Healthcare’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.39 EPS. As a group, research analysts anticipate that Acadia Healthcare Company Inc will post 1.86 EPS for the current year.
Several brokerages recently weighed in on ACHC. Raymond James reduced their price target on shares of Acadia Healthcare from $40.00 to $35.00 and set an “outperform” rating for the company in a research report on Wednesday, May 6th. Zacks Investment Research raised shares of Acadia Healthcare from a “hold” rating to a “strong-buy” rating and set a $28.00 price target for the company in a research report on Tuesday, July 7th. Wells Fargo & Co reissued a “hold” rating on shares of Acadia Healthcare in a research report on Tuesday, May 5th. Credit Suisse Group reduced their price target on shares of Acadia Healthcare from $33.00 to $28.00 and set a “neutral” rating for the company in a research report on Wednesday, May 6th. Finally, Deutsche Bank reduced their price target on shares of Acadia Healthcare from $32.00 to $28.00 and set a “hold” rating for the company in a research report on Thursday, May 7th. One analyst has rated the stock with a sell rating, seven have issued a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $32.00.
In other news, Director Reeve B. Waud sold 122,311 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $26.15, for a total value of $3,198,432.65. Following the sale, the director now directly owns 25,765 shares in the company, valued at approximately $673,754.75. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.60% of the company’s stock.
About Acadia Healthcare
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.
Featured Article: Momentum Investing
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company Inc (NASDAQ:ACHC).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.